Stool Microbiome and Metabolome Differences between Colorectal Cancer Patients and Healthy Adults
Open accessThe DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Abstract
In this study we used stool profiling to identify intestinal bacteria and metabolites that are differentially represented in humans with colorectal cancer (CRC) compared to healthy controls to identify how microbial functions may influence CRC development. Stool samples were collected from healthy adults (n = 10) and colorectal cancer patients (n = 11) prior to colon resection surgery at the University of Colorado Health-Poudre Valley Hospital in Fort Collins, CO. The V4 region of the 16s rRNA gene was pyrosequenced and both short chain fatty acids and global stool metabolites were extracted and analyzed utilizing Gas Chromatography-Mass Spectrometry (GC-MS). There were no significant differences in the overall microbial community structure associated with the disease state, but several bacterial genera, particularly butyrate-producing species, were under-represented in the CRC samples, while a mucin-degrading species, Akkermansia muciniphila, was about 4-fold higher in CRC (p<0.01). Proportionately higher amounts of butyrate were seen in stool of healthy individuals while relative concentrations of acetate were higher in stools of CRC patients. GC-MS profiling revealed higher concentrations of amino acids in stool samples from CRC patients and higher poly and monounsaturated fatty acids and ursodeoxycholic acid, a conjugated bile acid in stool samples from healthy adults (p<0.01). Correlative analysis between the combined datasets revealed some potential relationships between stool metabolites and certain bacterial species. These associations could provide insight into microbial functions occurring in a cancer environment and will help direct future mechanistic studies. Using integrated "omics" approaches may prove a useful tool in identifying functional groups of gastrointestinal bacteria and their associated metabolites as novel therapeutic and chemopreventive targets.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“a few cross-sectional studies reported that patients with CRC had a lower abundance of butyrate-producing species and lower fecal levels of butyrate than controls (Table 1).97, 133–135”
From Influence of the Gut Microbiome, Diet, and Environment on Risk of Colorectal Cancer (2020) · cites this paper as [97]
In the citing paper
“Nevertheless, A. muciniphila has previously been linked to an increased burden of CRC in human and mice,25–27”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Naïve Bayesian Classifier for Rapid Assignment of rRNA Sequences into the New Bacterial Taxonomy
Wang, Q., Garrity, G. M., Tiedje, J. M., & Cole, J. R. (2007) · Applied and Environmental Microbiology · doi:10.1128/aem.00062-07 · Cited by 19,885
Schloss, P. D., Westcott, S. L., Ryabin, T., Hall, J. R., Hartmann, M., Hollister, E. B., Lesniewski, R. A., Oakley, B. B., Parks, D. H., Robinson, C. J., et al. (2009) · Applied and Environmental Microbiology · doi:10.1128/aem.01541-09 · Cited by 19,549
An obesity-associated gut microbiome with increased capacity for energy harvest
Turnbaugh, P. J., Ley, R. E., Mahowald, M. A., Magrini, V., Mardis, E. R., & Gordon, J. I. (2006) · Nature · doi:10.1038/nature05414 · Cited by 12,444 · cited 2×
“A healthy gastrointestinal system relies on a balanced commensal biota to regulate processes such as dietary energy harvest [1], metabolism of microbial and host derived chemicals [2], and immune modulation [3].”
BackgroundDe Filippo, C., Cavalieri, D., Di Paola, M., Ramazzotti, M., Poullet, J. B., Massart, S., Collini, S., Pieraccini, G., & Lionetti, P. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1005963107 · Cited by 5,579 · cited 2×
“Prevotella was a dominant genera reported in stool from children in a rural community in Burkina Faso but absent from a cohort of Italian children, and the study authors hypothesized that Prevotella helped maximize energy harvest from a plant-based diet [29].”
BackgroundSmith, C. A., Want, E. J., O'Maille, G., Abagyan, R., & Siuzdak, G. (2006) · Analytical Chemistry · doi:10.1021/ac051437y · Cited by 5,262
Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma
Castellarin, M., Warren, R. L., Freeman, J. D., Dreolini, L., Krzywinski, M., Strauss, J., Barnes, R., Watson, P., Allen-Vercoe, E., Moore, R. A., et al. (2012) · Genome Research · doi:10.1101/gr.126516.111 · Cited by 2,043
Genomic analysis identifies association of Fusobacterium with colorectal carcinoma
Kostic, A. D., Gevers, D., Pedamallu, C. S., Michaud, M., Duke, F., Earl, A. M., Ojesina, A. I., Jung, J., Bass, A. J., Tabernero, J., et al. (2012) · Genome Research · doi:10.1101/gr.126573.111 · Cited by 1,960
Nicholson, J. K., & Lindon, J. C. (2008) · Nature · doi:10.1038/4551054a · Cited by 1,886
Microbes in Gastrointestinal Health and Disease
Neish, A. S. (2009) · Gastroenterology · doi:10.1053/j.gastro.2008.10.080 · Cited by 1,386
Png, C. W., Lindén, S. K., Gilshenan, K. S., Zoetendal, E. G., McSweeney, C. S., Sly, L. I., McGuckin, M. A., & Florin, T. H. J. (2010) · American Journal of Gastroenterology · doi:10.1038/ajg.2010.281 · Cited by 1,364 · cited 2×
“This bacterium is a common member of the colonic microbiota and was recently shown to be reduced in irritable bowel syndrome and Crohn’s Disease [32]; however a more recent report showed increased A. muciniphila in ulcerative colitis-associated pouchitis [33].”
Background
Research works printed but not linked: 1
- J Byrd, 2004, Mucins and mucin binding proteins in colorectal cancer, Cancer and Metastasis Reviews, 23, 77, 10.1023/A:1025815113599 · DOI · Paper page
Cited by
Items 501–600 of 642
Mikrobielle Biomarker zur Krebsfrüherkennung
Voigt, A. Y., Zeller, G., & Bork, P. (2017) · DMW - Deutsche Medizinische Wochenschrift · doi:10.1055/s-0042-110193 · Cited by 6
“▪ Metabolite aus mikrobieller Verstoffwechelung von Nahrungsbestandteilen ● Verstoffwechselung von rotem Fleisch und Lipiden begünstigt die Entstehung kardiovaskulärer Erkrankungen [26, 27] ● vermehrte Verstoffwechselung von Amino- säuren begünstigt die Darmkrebsentstehung [28] ▪ Virulenzgene/Toxine z. B. assoziiert m…”
BackgroundGebreselassie, E. E. E., Jackson, M. I., Yerramilli, M., & Jewell, D. E. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/324327 · Cited by 9
“This suggests that the increased fecal excretion of threonine is 338 associated with the degradation of the mucin layer as reported by Weir et al, (39).”
BackgroundInfluentialCitraconate promotes the malignant progression of colorectal cancer by inhibiting ferroptosis
Mai, Z.-J., Li, Y., Zhang, L., & Zhang, H. (2024) · American Journal of Cancer Research · doi:10.62347/lwrs3363 · Cited by 7
Shang, J., Liu, L., Yang, S., Duan, B., Xie, S., & Meng, X. (2024) · Foods · doi:10.3390/foods13193054 · Cited by 7
Neumann, G., Wall, R., Rangel, I., Marques, T. M., & Repsilber, D. (2018) · BMC Systems Biology · doi:10.1186/s12918-018-0667-6 · Cited by 6
“Some of these are SCFA- and specifically butyrate-producers [11, 37, 53, 56].”
BackgroundMicrobes Contribute to Chemopreventive Efficacy, Intestinal Tumorigenesis, and the Metabolome
Ferrara, C. R., Bai, J. D. K., McNally, E. M., Putzel, G., Zhou, X. K., Wang, H., Lang, A., Nagle, D. A., Denoya, P. I., Krumsiek, J., et al. (2022) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-22-0244 · Cited by 6
The Role of the Human Gutome on Chronic Disease
Hoefer, C. C., Hollon, L. K., & Campbell, J. A. (2022) · Clinics in Laboratory Medicine · doi:10.1016/j.cll.2022.09.015 · Cited by 5
Racial disparity in colorectal cancer: Gut microbiome and cancer stem cells
Goyal, S., Nangia‐Makker, P., Farhana, L., Yu, Y., & Majumdar, A. P. N. (2016) · World Journal of Stem Cells · doi:10.4252/wjsc.v8.i9.279 · Cited by 7
Arya, L. A., Richter, H. E., Jelovsek, E., Gantz, M. G., Cichowski, S. B., Zyczynski, H. M., Dyer, K. Y., Siddiqui, N. Y., Carberry, C. L., Broeckling, C. D., et al. (2017) · Neurourology and Urodynamics · doi:10.1002/nau.23360 · Cited by 5
“9% to 31% with standard deviations of 5% to 8%.(13,22) Our sample size calculation is conservatively based on a standard deviation of 8% for the proportion of butyrate/total SCFA FIGURE 1 The presumed effects of stool metabolites on gut motility and sensation.”
MethodAzlan, P. I. H. M. M., Chin, S., Low, T. Y., Neoh, H., & Jamal, R. (2019) · PROTEOMICS · doi:10.1002/pmic.201800176 · Cited by 5
Mechanistic and Therapeutic Advances in Colon Cancer: A Systematic Review
Xiu-jun, L., Han, Y., Zhang, A., Miao, J., Sun, H., Ge, Y., Wu, F., & Wang, X. (2019) · Open Journal of Proteomics and Genomics · doi:10.17352/ojpg.000008 · Cited by 5
“Metabolomics can be used to demonstrate the role of gut microbiota and to demonstrate that the relevant metabolites of the gut fl ora can serve as new preventive and chemical targets [73,74].”
BackgroundGrowth rate alterations of human colorectal cancer cells by 157 gut bacteriaPreprint
Taddese, R., Garza, D. R., Ruiter, L. N., de Jonge, M. I., Belzer, C., Aalvink, S., Nagtegaal, I. D., Dutilh, B. E., & Boleij, A. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2019.12.14.876367 · Cited by 5
Obesity, type 2 diabetes and cancers of the digestive system
Cernea, S., Crișan, D., Lăcătușu, C.-M., Zaharia, O., & Gancheva, S. (2026) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2026.02.003 · Cited by 5
Shahbazi, T., Bakhshi, B., Rasekhi, A., Fazeli, M. S., & Fallah, F. (2024) · Iranian Journal of Medical Microbiology · doi:10.30699/ijmm.18.2.106 · Cited by 4
Zhao, L., Fang, Y., Zhang, J., Chen, W., Ji, H., Zhao, J., Wang, D., & Tang, D. (2024) · Clinical Medicine Insights Oncology · doi:10.1177/11795549241307632 · Cited by 4
SMAD4 mutation drives gut microbiome shifts toward tumor progression in colorectal cancer
Gates, T. J., Wangmo, D., Bergerud, K. B., Keel, B. M., Staley, C. M., & Subramanian, S. (2025) · Discover Oncology · doi:10.1007/s12672-025-02580-6 · Cited by 6
“Akkermansia , a mucin-degrading bacterium, is often elevated in CRC patients [58, 59].”
Hasan, R., Kumar, A., Bose, S. K., Roy, R., Arora, A., Sharma, P., Nagumantri, S. P., Paul, D., & Choudhury, S. (2023) · The Open Microbiology Journal · doi:10.2174/18742858-v17-e230803-2023-7 · Cited by 4
Gómez‐Moreno, R., González‐Pons, M., Soto‐Salgado, M., Cruz-Correa, M. R., & Baerga‐Ortiz, A. (2019) · Diseases · doi:10.3390/diseases7010016 · Cited by 7
“It has been thought that the presence of this bacterium in CRC is due to the increased production of the glycoprotein mucin in diseased tissue [33].”
BackgroundInfluentialGC-MS-Based Metabolic Phenotyping
Deda, O., Gika, H., Raikos, Ν., & Theodoridis, G. A. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-812293-8.00004-9 · Cited by 8
Analysis of the chemical constituents of Thompson atemoya seed oil
Venceslau, A. D. F. A., Mendonça, A. C., Benedick, L. A. Z., Thomasi, S. S., Nunes, C. A., & Pinto, L. D. M. A. (2021) · Revista Brasileira de Fruticultura · doi:10.1590/0100-29452021015 · Cited by 4
Hullar, M. A. J., Sandstrom, R. S., Stamatoyannopoulos, J. A., Lampe, J. W., & Strate, L. L. (2019) · medRxiv · doi:10.1101/19001404 · Cited by 5
“(62-68) Succinate-producing genera such as Marvinbryantia have been shown to promote C.”
BackgroundGut Microbiome Profiles in Colorectal Cancer Patients in Iraq
Kadhim, F. J., Aziz, Z. S., & Ibrahim, K. S. (2025) · Microbiology Research · doi:10.3390/microbiolres16010022 · Cited by 4
Saylam, E., Özden, Ö., Yerlikaya, F. H., Sivrikaya, A., Yormaz, S., Arslan, U., Topkafa, M., & Maçin, S. (2025) · Pathogens · doi:10.3390/pathogens14090953 · Cited by 3
“Another study reported a significant increase in Akkermansia muciniphila in the gut microbiota of CRC patients [29].”
Infectious Organisms Associated With Colorectal Cancer
Park, M. Y., & Eslick, G. D. (2019) · Elsevier eBooks · doi:10.1016/b978-0-323-54843-4.00009-x · Cited by 3
Anand, S., Bose, C., Kaur, H., & Mande, S. S. (2021) · FEBS Letters · doi:10.1002/1873-3468.14107 · Cited by 3
The Role of the Human Gutome on Chronic Disease
Hoefer, C. C., Hollon, L. K., & Campbell, J. A. (2021) · Advances in Molecular Pathology · doi:10.1016/j.yamp.2021.06.003 · Cited by 3
Iwama, N., Matsuda, M., Tsuruta, M., Okabayashi, K., Shigeta, K., Kanai∥, T., & Kitagawa, Y. (2022) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-022-04477-1 · Cited by 3
“It has also been reported that Akkermansia muciniphila is increased in human CRC, although this phenomenon may be a result of CRC development (Amandine et al. 2013; Weir et al. 2013).”
BackgroundAlbóniga, O. E., Cubiella, J., Bujanda, L., Blanco, M. E., Lanza, B., Alonso, C., Jiménez, B. N., & Falcón‐Pérez, J. M. (2023) · Metabolites · doi:10.3390/metabo13030321 · Cited by 3
Rodriguez, D. M., Hintze, K. J., Rompato, G., Stewart, E. C., Barton, A. H., Mortensen, E., Green, P. A., Wettere, A. J. V., Thomas, A. J., & Benninghoff, A. D. (2023) · Nutrients · doi:10.3390/nu15061338 · Cited by 3
“Some studies have reported an elevated abundance of this bacterium in CRC patients [59,60], whereas others have reported reduced abundance in patients diagnosed with IBD [45,61–63].”
BackgroundDevelopment and treatment of colorectal cancer: Insights from multi‐kingdom microbiota
Hong, Y.-M., Song, D., Liu, N., & Wang, H. (2023) · Aging and Cancer · doi:10.1002/aac2.12063 · Cited by 3
Bacterial biomarkers: new aspects of colorectal tumors diagnosis: reality or fantasy
Shahbazi, T., Bakhshi, B., Fazeli, M. S., & Derakhshan-Nezhad, E. (2023) · European Journal of Cancer Prevention · doi:10.1097/cej.0000000000000760 · Cited by 3
Establishment of an early diagnosis model of colon cancerous bowel obstruction based on 1H NMR
Zeng, J., Peng, J., Jiang, H., Deng, P., Li, K., Long, D., & Wang, K. (2022) · PLoS ONE · doi:10.1371/journal.pone.0266730 · Cited by 4
Microbiome Analysis: Trends in Cancer Epidemiology, Challenges and Opportunities
Hebert, E. F. (2015) · International Journal of Cancer Research and Molecular Mechanisms · doi:10.16966/2381-3318.101 · Cited by 3
GC/MS-Based Metabolomics Approach to Evaluate the Effect of Jackyakgamcho-Tang on Acute Colitis
Seo, S.-H., Park, S., Kim, E.-J., Youn, D.-H., Lee, Y., Lee, S. Y., Bok, S., Park, D.-H., Seo, C., Byun, S., et al. (2019) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2019/4572764 · Cited by 4
Prognostic and Predictive Biomarkers for Colorectal Cancer
Manne, U., Putcha, B. K., Samuel, T., & Srivastava, S. (2017) · Wiley eBooks · doi:10.1002/9781118468869.ch13 · Cited by 3
Casimiro‐Soriguer, C. S., Loucera, C., Peña-Chilet, M., & Dopazo, J. (2020) · doi:10.21203/rs.2.21634/v1 · Cited by 3
“It has been described that cancer cells undergo modifications that include increased glutamine catabolism and over-expression of enzymes involved in glutaminolysis, including glutaminase [51], which is liberated to the gut [52] and promotes the proliferation of bacteria containing this bacterial module.”
BackgroundRuss, C. A., Zertalis, N. A., & Nanton, V. (2021) · medRxiv · doi:10.1101/2021.06.05.21258404 · Cited by 3
Stepanyan, A., Kotsafti, A., Rosato, A., Castagliuolo, I., Scarpa, M., Scarpa, M., on behalf of the IMMUNOREACT Study Group, Agostini, M., Angriman, I., Antoniutti, M., et al. (2026) · British Journal of Cancer · doi:10.1038/s41416-026-03443-9 · Cited by 3
“Establishing a validated, core predictive signature is essential to transition the gut microbiome from an exploratory biomarker to a precision medicine tool in the management of rectal cancer [65 – 71].”
Seliger, B., Mantke, R., Naß, N., Dammermann, W., Ocvirk, S., Kah, J., Kalinski, T., & Massa, C. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27104299 · Cited by 3
“The predominant secondary bile acid deoxycholic acid (DCA) was shown to act as a tumor-promoting agent in rodent models of CRC [112,113] and is present in high levels in CRC patients and individuals at high CRC risk [31,36,110,114].”
Regulation of Human Colorectal Cancer Cells in Tumor Spheroids by Sodium Butyrate
Takahama, Y., Kadoi, A., Tauchi, Y., Kasahara, S., Ishii, K., & Yano, T. (2025) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b25-00043 · Cited by 2
Abdi, H. A., Kordi-Tamandani, D. M., Lagzian, M., & Bakhshipour, A. (2022) · Jundishapur Journal of Microbiology · doi:10.5812/jjm-121119 · Cited by 2
“In other studies similar to our results, Prevotella (39, 40), Fusobacterium (19, 25, 36, 39, 41), Akkermansia (19, 42, 43), Leptotrichia (39, 43, 44), Streptococcus (20, 25,”
ResultColorectal cancer: risk factors and potential of dietary probiotics in its prevention
Arora, R., Sharma, S., & Kumar, B. (2022) · Proceedings of the Indian National Science Academy · doi:10.1007/s43538-022-00083-4 · Cited by 3
Germicidal and Antineoplastic Activities of Curcumin and Curcumin-Derived Nanoparticles
Makgoo, L., & Mbita, Z. (2023) · IntechOpen eBooks · doi:10.5772/intechopen.103076 · Cited by 2
Xiao, X., Long, W., Huang, T., Xia, T., Ye, R., Liu, Y., & Long, H. (2018) · Digestive Diseases and Sciences · doi:10.1007/s10620-018-5180-7 · Cited by 2
Kostopoulos, I. (2021) · doi:10.18174/531651 · Cited by 2
Barton, C. K., Hassel, D. M., Anders, K., & Weir, T. L. (2024) · Animals · doi:10.3390/ani14223203 · Cited by 1
Inoue, R., Hosomi, K., Park, J., Sakaue, H., Yumioka, H., Kamitani, H., Kinugasa, Y., Harano, K., Syauki, A. Y., Doi, M., et al. (2024) · Nutrients · doi:10.3390/nu16223839 · Cited by 1
“An increase in Phascolarctobacterium has been documented in early-stage colorectal cancer (CRC) patients, where elevated levels of succinate and lactate in fecal metabolites have been observed [35,36].”
Russ, C., Zertalis, N. A., & Nanton, V. (2024) · EMJ Gastroenterology · doi:10.33590/emjgastroenterol/ohyp9967 · Cited by 3
Fan, Y.-Y., Salinas, M. L., Mullens, D. A., Davidson, L. A., Goldsby, J. S., Ivanov, I. V., Jayaraman, A., Cai, J. J., Levy, L., Hullar, M. A. J., et al. (2025) · Journal of Nutrition · doi:10.1016/j.tjnut.2025.101287 · Cited by 2
Wang, H.-W., Li, W., Ma, Q.-J., Zhang, H.-Y., Quan, Y., & Zhu, Q. (2026) · Metabolites · doi:10.3390/metabo16010064 · Cited by 1
Microbiota-Derived Proteins Shape T Cell Responses in Healthy and Colorectal Cancer Subjects
Niccolai, E., Nannini, G., Martinelli, S., Puca, V., Luca, V. D., Fortuna, L., Cianchi, F., Carradori, S., Capasso, C., Grande, R., et al. (2026) · Biomedicines · doi:10.3390/biomedicines14010252 · Cited by 2
Multiomics Research Strategies in Cancer: A Growing and Innovative Field
Du, Z., Liu, X., Lv, Z., Wang, B., Xia, Y., Al-duais, W. A. M., Yan, L., Zhang, F., & Li, Y. (2026) · MedComm · doi:10.1002/mco2.70644 · Cited by 2
A bibliometric and text-mining analysis of lipidomics and metabolomics in human disease
Trejo-Castro, A. I., Marín‐Obispo, L. M., Carrión-Álvarez, D., Mora‐Godínez, S., Martínez‐Torteya, A., Hernández‐Brenes, C., & Martínez-Ledesma, E. (2026) · Frontiers in Physiology · doi:10.3389/fphys.2026.1727465 · Cited by 1
“More recent studies further highlight the role of the human microbiome in colorectal cancer development, while coinciding in the observation that phenylalanine is signi fi cantly increased in intramucosal carcinomas (Weir et al., 2013; Yachida et al., 2019).”
The gut microbiome and colorectal cancer
Dietz, M. A., Subramanian, S., & Staley, C. M. (2026) · Clinical Microbiology Reviews · doi:10.1128/cmr.00332-25 · Cited by 1
“In particular, a survey of stool samples from healthy adults and CRC patients found that the ratio of acetate to butyrate was greater in CRC patients (110).”
Epigenetic Effects of Gut Microbiota on Obesity and Gastrointestinal Cancers
Kuroiwa‐Trzmielina, J., & Hesson, L. B. (2016) · Energy balance and cancer · doi:10.1007/978-3-319-41610-6_7 · Cited by 1
Gómez‐Moreno, R., Martínez-Ramírez, R., Roche-Lima, A., Carrasquillo-Carrión, K., Pérez‐Santiago, J., & Baerga‐Ortiz, A. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00631 · Cited by 1
Cross-study analyses of microbial abundance using generalized common factor methods
Hayes, M. G., Langille, M. G. I., & Gu, H. (2023) · BMC Bioinformatics · doi:10.1186/s12859-023-05509-4 · Cited by 1
“…that have been previously associated with CRC in additional studies include Fusobacterium [10, 36], Porphorymonas [10, 36], Acidaminococcus [3], Phascolarctobacterium [44], Enterococcus [23], Gemella [23], Klebsiella [10], Prevotella [36], Solobacterium [46], and the Siphoviridae viruses [19].”
BackgroundINFLAMMATION AND COLON CANCER. MOLECULAR AND IMMUNOLOGICAL MECHANISMS
Kit, O. I., Nikipelova, E. A., Av, S., Zlatnik, E. Y., Novikova, I. A., Frantsiyants, E. M., Vladimirova, L. Y., Shatova, Y. S., Шевченко, А. И., & Pozdnyakova, V. V. (2018) · Voprosy Onkologii · doi:10.37469/0507-3758-2018-64-1-34-40 · Cited by 2
Heart failure and cancer: From active exposure to passive adaption
Du, Y., & Wu, T. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.992011 · Cited by 1
“Bacteroidetes, Firmicutes, Proteobacteria, and Actinobacteria are the four main bacterial species (144).”
BackgroundDNA Replication - Epigenetic Mechanisms and Gene Therapy Applications
Haidar, Z. S. (2023) · IntechOpen eBooks · doi:10.5772/intechopen.104310 · Cited by 1
Perspective Chapter: Epigenetic Therapy – The Future Treatment for Cancer
Thumu, S. C. R., Papanna, S. R., & Devi, S. M. (2023) · IntechOpen eBooks · doi:10.5772/intechopen.110641 · Cited by 2
Al-Khafaji, N. S. K., Al-Dahmoshi, H. O. M., Chabuck, Z. A. G., Mahdi, Z. A.-A., Akram, M., Sohail, A., Laila, U., Zainab, R., Khalil, M. T., Iftikhar, M., et al. (2023) · Medical Journal of Babylon · doi:10.4103/mjbl.mjbl_209_23 · Cited by 1
Akinrinde, A. S., Omotosho, O., Adetiba, R., Oyagbemi, A. A., & Omóbòwálé, T. O. (2023) · Iranian Journal of Toxicology · doi:10.61186/ijt.17.4.50 · Cited by 1
The Role of the Gut Microbiota in the Development of Colorectal Cancer
Николаевна, Ш. В., Goncharov, A. Е., Лаврентьевич, Л. Э., & Aslanov, B. I. (2024) · Fundamental and Clinical Medicine · doi:10.23946/2500-0764-2024-9-1-112-123 · Cited by 1
Differential impact of glycoprotein glycosylation on Akkermansia muciniphila growth dynamics
Zhang, J., Lyu, Y.-S., Voglmeir, J., & Liu, L. (2024) · Food Materials Research · doi:10.48130/fmr-0024-0013 · Cited by 2
Wei, L., Tang, W., Lu, W., Zhu, S., Zhang, Y., & Chen, Z. (2025) · Optics Express · doi:10.1364/oe.569219 · Cited by 1
Epigenetics and the Microbiome
Pevsner‐Fischer, M., Zmora, N., Braverman, S., & Elinav, E. (2017) · Springer eBooks · doi:10.1007/978-3-319-31143-2_35-1 · Cited by 2
Ba, S., Yudin, S. M., Zagaynova, A. V., & Shevyreva, M. P. (2019) · Journal of microbiology epidemiology immunobiology · doi:10.36233/0372-9311-2019-4-105-115 · Cited by 3
Lakshmanan, A. P., Murugesan, S., & Bangarusamy, D. K. (2022) · Springer eBooks · doi:10.1007/978-981-16-6226-3_4 · Cited by 1
Li, S., Zhang, S., Li, B., Sha, S., Kang, J., Li, P., Zhang, A., Ji, Q., Lv, Q., Zhang, X., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.01.29.926196 · Cited by 1
The Important Role of Breast Microbiota in Breast CancerPreprint
Su, K.-Y., Lee, W.-L., & Balasubramaniam, V. R. M. T. (2020) · Preprints.org · doi:10.20944/preprints202010.0437.v1
Profiling the Gut Microbiome: Practice and Potential
Manvar, T., & Lakhujani, V. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-809633-8.20503-7 · Cited by 1
Characterization of the Fecal Microbiota in Gastrointestinal Cancer Patients and Healthy ControlsPreprint
Li, N., Bai, C., Guan, Y., Zhao, L., Ge, Y., & Li, X. (2020) · doi:10.21203/rs.3.rs-37119/v1 · Cited by 1
“muciniphila were also found to be increased in the feces of patients with colorectal cancer[36, 37].”
BackgroundIslam, M. Z., Tran, M. A., Xu, T., Tierney, B. T., Patel, C. J., & Kostic, A. D. (2021) · Research Square · doi:10.21203/rs.3.rs-1195626/v1 · Cited by 1
The Gut Microbiota and Epigenetics
Lundstrom, K. H. (2016) · Journal of Nutritional Therapeutics · doi:10.6000/1929-5634.2016.05.02.4
Mikrobielle Biomarker zur Krebsfrüherkennung
Voigt, A. Y., Zeller, G., & Bork, P. (2018) · TumorDiagnostik & Therapie · doi:10.1055/s-0043-124940
“– vermehrte Verstoffwechselung von Aminosäuren begünstigt die Darmkrebsentstehung [28] ▪ Virulenzgene/Toxine z.”
BackgroundJain, A. (2018) · doi:10.32657/10220/46936
“higher concentrations of amino acids, saturated fatty acids, and ursodeoxycholic acid were reported in fecal samples of colorectal cancer patients [41].”
BackgroundMetabolome and Microbiome From Infancy to Elderly
Cortez, R. V., Moreira, L. N., & Taddei, C. R. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-815249-2.00008-7
Integration and visualisation of clinical-omics datasets for medical knowledge discovery
Homola, D. (2017) · Spiral (Imperial College London) · doi:10.25560/67647
“We can quickly check this, by selecting an extreme range of values on the BMI bar-chart (60-80), then slowly dragging this selection towards the minimum values (20-40).”
BackgroundGut Microbiota as Signatures in Non-communicable Diseases and Mucosal Immunity
Behera, S. K., Praharaj, A. B., Chalikonda, G., Srivani, G., & Mahapatra, N. (2020) · Diagnostics and therapeutic advances in GI malignancies · doi:10.1007/978-981-15-2017-4_11 · Cited by 1
Busi, S. B. (2018) · MOspace Institutional Repository (University of Missouri) · doi:10.32469/10355/67675
Who Inhabits Our Gut? Introducing the Human Gut Microbiota
Flint, H. J. (2020) · Fascinating life sciences · doi:10.1007/978-3-030-43246-1_5
Role of Gut Microbiome in Colorectal Cancer
Sun, X. (2020) · Springer eBooks · doi:10.1007/978-3-030-47384-6_7
Moskowitz, J. E. (2019) · MOspace Institutional Repository (University of Missouri) · doi:10.32469/10355/76253
Watanabe, D., Murakami, H., Ohno, H., Tanisawa, K., Konishi, K., Todoroki-Mori, K., Tsunematsu, Y., Sato, M., Ogata, Y., Miyoshi, N., et al. (2020) · doi:10.21203/rs.3.rs-106339/v1
“In addition, studies in CRC patients have noted lower levels of propionate and butyrate [34] and higher levels of valeric acid, isobutyric acid, and isovaleric acid [35] in SCFAs derived from fecal samples compared to healthy controls.”
BackgroundMaisonneuve, C. (2019) · TSpace (University of Toronto)
Epigenetics and the Microbiome
Pevsner‐Fischer, M., Zmora, N., Braverman, S., & Elinav, E. (2019) · Springer eBooks · doi:10.1007/978-3-319-55530-0_35 · Cited by 2
Smilde, A. K., Næs, T., & Liland, K. H. (2022) · Wiley eBooks · doi:10.1002/9781119600978.biblio
Blurring the line between opportunistic pathogens and commensals
Jia, H. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-91369-0.00007-8 · Cited by 1
Traditionally brewed rice beverage alters gut microbiota and metabolites in micePreprint
Bhaskar, B., Adak, A., Das, S., & Khan, M. R. (2021) · Research Square · doi:10.21203/rs.3.rs-221115/v1
“Page 5/18 Fecal sample preparations and the GC-MS run program were followed as per protocol described elsewhere (Weir et al. 2013).”
Method
Metadata
- Authors
- Weir, T. L., Manter, D. K., Sheflin, A. M., Barnett, B. A., Heuberger, A. L., & Ryan, E. P.
- Affiliations
- Colorado State University (US)
- Agricultural Research Service (US)
- Corresponding author
- Weir, Tiffany L.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2013-08-06
- Volume
- 8
- Issue
- 8
- Pages
- e70803
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3735522
- OpenAlex
- W2115450300
- Cited by
- 642
- References
- 48
- Citations by year
- 2026: 15 · 2025: 40 · 2024: 37 · 2023: 60 · 2022: 66 · 2021: 67 · 2020: 67 · 2019: 74 · 2018: 58 · 2017: 53 · 2016: 54 · 2015: 29 · 2014: 21 · 2013: 1
- FWCI
- 15.69
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- National Institutes of Health
- National Cancer Institute (R03CA150070)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolomics and Mass Spectrometry Studies
- Health Sciences › Dentistry › Periodontics › Oral microbiology and periodontitis research
- Keywords
- colorectal cancer, gut microbiota, Akkermansia muciniphila, butyrate, short-chain fatty acids, mucin degradation, ursodeoxycholic acid, bile acids, amino acids, polyunsaturated fatty acids, monounsaturated fatty acids, acetate, 16S rRNA gene, chemoprevention
- MeSH terms
- Adult, Aged, Aged, 80 and over, Carcinoma in Situ, Feces, Female, Health, Humans, Male, Middle Aged, Colorectal Neoplasms, Case-Control Studies, Metabolome, Microbiota
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.